| Vista Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524711 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE427C01021 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 7.25 |
Market Cap(₹Cr) : 46.16 |
Face Value(₹) : 2.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 2.42 | 1.46 | 1.52 | 3.23 | 2.56 | 2.49 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2.42 | 1.46 | 1.52 | 3.23 | 2.56 | 2.49 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.09 | 0.19 | 0.00 | 0.24 | 0.12 | 0.01 |
| Total Income | 2.51 | 1.65 | 1.52 | 3.47 | 2.68 | 2.50 |
| Total Expenditure | 5.42 | 4.90 | 2.63 | 4.14 | 4.07 | 3.32 |
| PBIDT | -2.92 | -3.25 | -1.11 | -0.67 | -1.39 | -0.82 |
| Interest | 0.18 | 0.18 | 0.19 | 0.21 | 0.22 | 0.25 |
| PBDT | -3.09 | -3.42 | -1.30 | -0.88 | -1.62 | -1.07 |
| Depreciation | 0.19 | 0.20 | 0.18 | 0.18 | 0.19 | 0.18 |
| Tax | 0.00 | 0.00 | 0.00 | 0.43 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.96 | -1.03 | -0.19 | 0.00 | -0.48 | -0.28 |
| Reported Profit After Tax | -2.32 | -2.59 | -1.29 | -1.50 | -1.32 | -0.97 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -2.32 | -2.59 | -1.29 | -1.50 | -1.32 | -0.97 |
| EPS (Unit Curr.) | -0.41 | -0.42 | -0.22 | -0.79 | -0.07 | -0.16 |
| EPS (Adj) (Unit Curr.) | -0.41 | -0.42 | -0.22 | -0.79 | -0.07 | -0.16 |
| Calculated EPS (Unit Curr.) | -0.38 | -0.42 | -0.21 | -0.24 | -0.21 | -0.16 |
| Calculated EPS (Adj) (Unit Curr.) | -0.38 | -0.42 | -0.21 | -0.24 | -0.21 | -0.16 |
| Calculated EPS (Ann.) (Unit Curr.) | -1.51 | -1.68 | -0.84 | -0.97 | -0.86 | -0.63 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -1.51 | -1.68 | -0.84 | -0.97 | -0.86 | -0.63 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 12.31 | 12.31 | 12.31 | 12.31 | 12.31 | 12.31 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -120.66 | -222.60 | -73.03 | -20.74 | -54.30 | -32.93 |
| PBDTM(%) | -127.69 | -234.25 | -85.53 | -27.24 | -63.28 | -42.97 |
| PATM(%) | -95.87 | -177.40 | -84.87 | -46.44 | -51.56 | -38.96 |
